Free Consultation

Top Hospitals in India

Apollo Hospital Apollo Hospital

Fortis Hospital Fortis Hospital

Artemis Hospital Artemis Hospital

Max Hospital Max Hospital

Asia Columbia Group of Hospitals
Asia Columbia Group of Hospitals

Medanta Hospital Medanta Hospital

Asian Heart Institute
Asian Heart Institute

Wockhardt Hospital
Wockhardt Hospital

Hiranandani Hospital
Hiranandani Hospital

Sir Ganga Ram Hospital
Sir Ganga Ram Hospital

Jaslok Hospital Jaslok Hospital

Lilavati Hospital Lilavati Hospital

Kokilaben Hospital
Kokilaben Hospital

Narayana Hrudayalaya
Narayana Hrudayalaya

Global Hospitals Global Hospitals

Jupiter Hospital Jupiter Hospital

Sex Selection Treatment in India

IVF (Fertility Treatment)

IVF Fertility Treatment Human sex selection can be accomplished at pre-implantation of an embryo. It has been marketed under the title family balancing. There are two major types of pre-implantation methods which can be used for sex selection.

Human sex selection can be accomplished at pre-implantation of an embryo. It has been marketed under the title family balancing. There are two major types of pre-implantation methods which can be used for sex selection.

  • Sperm sorting - The separation of X Chromosome sperm from Y Chromosome sperm. The resulting sorted sperm are used in either artificial insemination or in-vitro fertilization (IVF) procedures.
  • Pre-implantation genetic diagnosis (PGD) - In sex selection cases, embryos resulting from IVF procedures are genetically tested for X or Y Chromosomes. The embryos of the desired sex are then implanted..

More support for sex selection

The American Society for Reproductive Medicine has paved the way for its members to help couples choose the sex of their babies. Australian professionals, however, remain divided on the issue. A report from the American Society's Ethics Committee says that the use of medical technologies by couples seeking "gender variety" in their offspring is acceptable under certain conditions. The stand is a relaxation of an earlier position, which held that the use of IVF and pre-implantation genetic diagnosis for the sole purpose of sex selection should be "discouraged" because it holds the risk of "unwarranted gender bias, social harm and the diversion of medical resources from genuine medical need". "They've certainly become more liberal in their view," comments Dr Julian Savulescu of the Murdoch Childrens Research Institute. Dr Savulescu is an advocate for sex selection. He argues that objections to medically assisted sex selection based on possible harm to the child, the parents, or society, are not compelling, particularly in Australia.

In addition to pre-implantation genetic diagnosis (PGD), a foetus's sex can also be tested using chorionic villus sampling (CVS) at around 11 weeks, followed by abortion if it is the 'wrong' sex. While Dr Savulescu acknowledges that the CVS technique carries increased risks of miscarriage, he says that PGD has been shown to be safe and that 300 children had been born world-wide using the technology. Professor Gab Kovacs, of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists and Monash IVF, says the College does not condone discarding embryos on the basis of sex. However, he says, there may be an argument for sex selection in some circumstances. "One must look at the best interests of the child. If the parents are obsessed enough to try and have a child of a particular sex, it may be in the child's best interest to make sure it is the sex that is desired."

There are no national laws governing sex selection in Australia. Sex selection is available through a company in Sydney but is banned in some states, including Victoria and South Australia.

Sex selection "inevitable"

The University of Tasmania's Dr Chris Newell says that the ethical acceptability of embryo sex selection is "inevitable" if people accept the selection of embryos on the basis of disease."It's a logical extension," he says. "If you argue it's the parent's right to choose, how can you say it's okay for them to choose on the basis of one characteristic but not on another?"Dr Savulescu argues there may be a case for differential application of sex selection technologies. They may be less appropriate in countries like India and China, where it may be better to try and reduce systematic discrimination against females rather than the number of females born, he says.However, Dr Savulescu does not think social conditions in different countries can be used to argue against selection on the basis of disability - because disability, unlike gender, he says, is "inherently bad".Dr Newell disagrees: "Disability is not inherently bad. Most of the problems caused by disability are the stigma and discrimination by society. Just like gender, the acceptability of disability and ethnicity depends on society."Dr Newell describes the debate on this issue in Ausralia as "impoverished".

"We need to move beyond the right of couples to choose, to asking whether it is good ethics to select various attributes for our children," he says.

Boy or Girl?

News of a US study, launched to investigate the social effects of allowing parents to choose the sex of their child, has re-focused attention on the contentious issues surrounding sex selection. Dominique Driver delves into the UK government's current policy on the use of reproductive technologies, and asks how the public in the UK feels about sex selection.

Sandra Carson and her team needed nine years to gain approval from their review board at Baylor College of Medicine in Houston, Texas. The study will be made possible by a technique known as Pre-implantation Genetic Diagnosis (PGD). PGD involves extracting the DNA of a single cell of an eight-cell stage embryo created by In Vitro Fertilisation (IVF) for determining the sex as well as checking for genetic abnormalities. After result evaluation, the 'desired' embryos can then be implanted into the mother's uterus. At least fifty couples are currently lined up to take part in the trial, but only those who already have a child of the opposite sex will be enrolled, a practice known as 'family balancing'. The use of PGD for sex selection is legal in the US, though, the American Society for Reproductive Medicine (ASRM) and the American College of Obstetricians and Gynecologists (ACOG) have openly stated their opposition to using PGD in this way. Across the Atlantic, at the UK front, social sex selection is currently banned and the Human Fertility and Embryology Authority (HFEA) who regulate the all reproductive technology will only licence PGD for serious medical conditions.

Yet not everyone is in agreement over the HFEA's decision to invoke the precautionary principle when it comes to reproductive technology. Earlier this year, after reviewing the 1990 Human Fertilisation and Embryology (HFE) Act, the House of Commons Science and Technology Committee tentatively recommended that the ban should be withdrawn. The committee contended that there was little evidence to support the HFEA's position: "It concerns us that the potential for harm is often quoted without recourse to a growing body of evidence of its absence... the bonus should be on those who oppose sex selection for social reasons using PGD to show harm from its use." Although the committee recognised that the majority of the British public are currently against sex selection, they concluded that: "on balance we find no adequate justification for prohibiting the use of sex selection for family balancing". However they steered clear of recommending the more controversial uses of sex selection, such as in helping rebuild a family that has suffered the loss of a child, or to support economic, cultural or social preferences for one gender over the other. These are often considered more problematic because of the possible psychological effects on the families, the view that these practices may be sexually discriminating, and the potential they have to skew the gender ratio in certain communities.

Together with social and demographic considerations, social sex selection raised an array of ethical concerns. Some fear that by allowing sex selection for social purposes we are no longer valuing children for who they are, and may be leaving the door open to the selection of further non-medical traits, creating so-called 'designer babies'. Dr Rony Duncan, Researcher in the Medical Ethics Unit at Imperial College, believes that although there is an ethical distinction between sex selection for medical reasons and sex selection for social purposes, both are ethically acceptable. "Some people with two boys want a girl. Some people want a boy first. Others only want girls. People have had preferences about the sex of their children for centuries. We now simply have an accurate way of helping them". He explains that in ethical terms the difference lies in the motivation for each, but argues that there is nothing inherently wrong with wanting to have a child of one sex over the other. "There is no evidence that having a preference for the sex of your child makes you a bad parent, or harms the future child. Parents should be able to choose the sex of their children, whether it's to increase the chances of them having a healthy child or simply because they want to".

However, while the current ban remains in place it will be impossible for UK researchers to assemble conclusive evidence on the effects of social sex selection, something the US trial will hopefully go some way towards providing. Dr Peter Mills, Policy Development and Co-ordination Manager at the HFEA agrees that the US study may help to shed light on these issues: "Although the Authority has indicated that it does not regard sex selection by PGD for non-medical reasons as an appropriate use of reproductive technology and would therefore be unlikely to licence it in the UK, the results of any well-designed follow-up research may well advance some of the arguments around this contentious use of the technology". Where does that leave us now? In response to the recommendations of the House of Commons Science and Technology Committee, the government issued a statement maintaining that: "The government has no plans to alter this position to allow sex selection other than for compelling medical reasons." But as part of its review of the HFE Act, the government has also conducted a public consultation into whether sex selection should be permitted for family balancing purposes, the results of which should be available next year. Dr Mills of the HFEA insists that in the meantime: "The Authority will continue to keep emerging evidence and argument under review, including information about the risks associated with the techniques and about the consequences of their use."

So should we be embracing this potential use of reproductive technology? The jury is still out, but if pressure from the government continues to grow, the HFEA may be forced to rethink its position, or provide compelling justification for standing by its current policy. The assertion that the bulk of the general public oppose social sex selection may simply not be enough.

Sex Selection Method India,Cost Sex Selection Method,Sex Selection India,Low Cost Sex Selection Delhi India,Sex Selection Method Hospital Delhi,Sex Selection Mumbai Hospital,Cost Sex Selection Method Mumbai,Delhi-India,Low Cost Sex Selection Method Hospital,Affordable Sex Selection Hospital Mumbai,Delhi,Cost Sex Selection Method Hospital Delhi,Cost Sex Selection Method Mumbai,Affordable Sex Selection Hospital Bangalore, Pune, Ahemedabad, Chennai, Hyderabad,Sex Selection Method Chennai,Cost Sex Selection Ahmedabad Sex Selection Hyderabad Low Cost Sex Selection Method Pune

medical tourism company in india